title: [Acute severe fibrosing hepatitis associated with ciprofibrate treatment].
authors.forename: J
authors.initials: J
authors.lastname: Dumortier
authors.forename: R
authors.initials: R
authors.lastname: Slim
authors.forename: M
authors.initials: M
authors.lastname: Chevallier
authors.forename: O
authors.initials: O
authors.lastname: Boillot
authors.forename: J L
authors.initials: JL
authors.lastname: Thaunat
authors.forename: E
authors.initials: E
authors.lastname: Vaillant
authors.forename: T
authors.initials: T
authors.lastname: Vial
authors.forename: B
authors.initials: B
authors.lastname: Bellemin
authors.forename: P
authors.initials: P
authors.lastname: Paliard
authors.forename: J Y
authors.initials: JY
authors.lastname: Scoazec
mesh_terms: D000208:Acute Disease; D000368:Aged; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002995:Clofibric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D058607:Fibric Acids; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008103:Liver Cirrhosis / Q000139:chemically induced*
chemical_list: D058607:Fibric Acids; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; C019304:ciprofibrate